State Street SPDR S&P Health Care Equipment ETF
XHE
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 1 Iron Street Boston MA United States of America 2210
- IPO Date
- Jan 27, 2011
- CIK
- 0001064642
- Website
- ssga.com
- Similar Companies
- Business
- SPDR S&P Health Care Equipment ETF (XHE) is an exchange-traded fund that seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Health Care Equipment Select Industry Index, an equal-weighted benchmark comprising U.S.-listed stocks in the health care equipment and supplies sub-industry. The fund invests substantially all, but at least 80%, of its total assets in the securities comprising the index or depositary receipts representing those securities, including common stocks, preferred stocks, securities convertible into common stocks, real estate investment trusts (REITs), American depositary receipts (ADRs), and global depositary receipts (GDRs); it may also utilize exchange-traded products (ETPs), ETP options, exchange-traded futures, swaps, and cash or cash equivalents for investment purposes. Launched on January 26, 2011, and issued by State Street Global Advisors (SSGA), a division of State Street Global Advisors, Inc., headquartered in Boston, Massachusetts, XHE primarily targets institutional and retail investors seeking targeted exposure to the U.S. health care equipment sector, with holdings diversified across approximately 66 small-, mid-, and large-cap companies such as STAAR Surgical Company, Alphatec Holdings, IDEXX Laboratories, Artivion, LivaNova, QuidelOrtho Corp., Glaukos Corp., and Tandem Diabetes Care Inc. Operations focus on the U.S. equity markets, with over 91% geographic exposure to the United States and minor allocations to Ireland, Jersey, and the United Kingdom. In recent developments, the fund reported total assets under management of approximately $135.89 million to $213 million as of late 2024 and early 2025, reflecting net outflows of $60.76 million over the prior year amid a turnover ratio of 42% (or 12% per latest N-PORT filing); it maintained a net expense ratio of 0.35%, a weighted average dividend yield of 0.44%, and traded at a slight discount to NAV of -0.25%. No major acquisitions, funding rounds, partnerships, new product launches, or structural reorganizations have been announced for XHE or its issuer SSGA within the last 1-2 years, with the fund continuing its established strategy of equal-weighted indexing without significant shifts in mandate or holdings composition beyond routine quarterly rebalancing aligned with the S&P Health Care Equipment Select Industry Index.